Development of Levofloxacin Inhalation Solution to Treat Pseudomonas Aeruginosa in Patients With Cystic Fibrosis

Therapeutic Advances in Respiratory Disease- United Kingdom

doi 10.1177/1753465813508445

Full Text

Abstract

Available in

Date

Authors

Publisher

SAGE Publications

Related search

Immunization of Noncolonized Cystic Fibrosis Patients Against Pseudomonas Aeruginosa

Journal of Infectious Diseases
Infectious DiseasesAllergyImmunology
1994English

Eradication of Pseudomonas Aeruginosa in Cystic Fibrosis

European Respiratory Journal
MedicinePulmonaryRespiratory Medicine
2006English

The Susceptibility of Pseudomonas Aeruginosa Strains From Cystic Fibrosis Patients to Bacteriophages

PLoS ONE
Multidisciplinary
2013English

Antibiotic Perturbation of Mixed-Strain Pseudomonas Aeruginosa Infection in Patients With Cystic Fibrosis

BMC Pulmonary Medicine
PulmonaryRespiratory Medicine
2017English

Efficacy of Aerosol MP-376, a Levofloxacin Inhalation Solution, in Models of Mouse Lung Infection Due to Pseudomonas Aeruginosa

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
2009English

Treatment of Pseudomonas Aeruginosa Colonisation in Cystic Fibrosis.

Archives of Disease in Childhood
Child HealthPediatricsPerinatology
1989English

Pseudomonas Aeruginosa in Cystic Fibrosis: A Chronic Cheater

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
2019English

Low Rates of Pseudomonas Aeruginosa Misidentification in Isolates From Cystic Fibrosis Patients

Journal of Clinical Microbiology
Microbiology
2009English

Sera From Adult Patients With Cystic Fibrosis Contain Antibodies to Pseudomonas Aeruginosa Type III Apparatus

Infection and Immunity
ParasitologyInfectious DiseasesImmunologyMicrobiology
2001English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy